#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Human papilloma virus immunisation Squamous cell carcinoma of the vulva Primary adrenal insufficiency Monogenic diabetes Fibrodysplasia ossificans progressiva Angiosarcoma Leukocyte adhesion deficiency type I Peritoneal neoplasm Transplant rejection Cutaneous calcification Bladder cancer Hepato-lenticular degeneration T-cell lymphoma Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    IgA nephropathy – Trials in Disease Primary biliary cholangitis – Diagnostics Encephalitis autoimmune – Basic Information Lymphatic malformation Haemophilia A without inhibitors – Life with Disease Turner’s syndrome – Diagnostics Pleural mesothelioma malignant – Treatment Lymphangioma – Life with Disease Tuberous sclerosis complex – Treatment Chordoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pemetrexed Diacid Monohydrate Hydroxychloroquine Sulfate Povidone Avalglucosidase Alfa Metronidazole BUDOPRUTUG Metformin Vancomycin Cefuroxime Sacubitril Piracetam HSP-CAR30 Sabirnetug Vatiquinone Doxylamine Hydrogen Succinate Mitoxantrone Hydrochloride Clofarabine Forimtamig Haemophilus Influenzae Csm-Gw More therapies…

    Learn about Your Condition

    Haemofiltration Complex regional pain syndrome Post procedural swelling Angiosarcoma non-metastatic Underweight Myeloproliferative neoplasm Richter's syndrome Orthostatic hypotension Foot deformity Necrotising myositis Oxygen saturation Pulmonary tuberculosis Erythema Precocious puberty Vulvovaginal candidiasis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • A study to evaluate the safety of REGN7041 in adults with active noninfectious uveitis affecting the back of the eye.

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Uveitis
    France

  • Effect of itraconazole on the blood levels of BI 1815368 after a single oral dose in healthy male subjects

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Itraconazole
    Germany

  • Comparison of Dexamethasone and Diclofenac Eye Drops After Glaucoma Surgery in Patients with Medically Uncontrolled Glaucoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Diclofenac Sodium
    Denmark

  • Study of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13

    Not recruiting

    2 1
    Investigated Diseases:
    • Retinitis pigmentosa
    Investigated Drugs:
    • ULTEVURSEN
    Belgium Denmark France Germany Italy The Netherlands

  • Study of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Vrdn-001
    • Sodium Chloride
    France Germany Hungary Italy Poland Spain

  • Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Ranibizumab
    • Fluorescein Sodium
    Austria Croatia Czechia France Germany Hungary +6
Previous Page
1 … 17 18 19 20 21 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!